749P Cardiotoxicity in patients treated with PARP-inhibitors
M. Blanco Clemente(Hospital Universitario Puerta de Hierro Majadahonda), C. Maximiano Alonso(Hospital Universitario Puerta de Hierro Majadahonda), Aranzazu González del Alba(Hospital Universitario Son Espases), Blanca Cantos Sánchez de Ibargüen(Hospital Universitario Puerta de Hierro Majadahonda), Míriam Méndez(Hospital Universitario Puerta de Hierro Majadahonda), Cristina Mitroi(Hospital Universitario Puerta de Hierro Majadahonda), B. Núñez García(Hospital Universitario Puerta de Hierro Majadahonda), M. Martínez Cutillas(Hospital Universitario Puerta de Hierro Majadahonda), Jorge González(Hospital Municipal de Badalona), Y. Garitaonaindía Díaz(Hospital Universitario Puerta de Hierro Majadahonda), B Menchén Viso(Hospital Universitario Puerta de Hierro Majadahonda)
Cited by 3
Related Papers
Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study
|The Lancet Oncology|2011|221
Ventricular Arrhythmias Among Implantable Cardioverter-Defibrillator Recipients for Primary Prevention
|Circulation Arrhythmia and Electrophysiology|2011|152
Usefulness of Two-Dimensional Strain Parameters to Diagnose Acute Rejection after Heart Transplantation
|Journal of the American Society of Echocardiography|2015|128
Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations
|Revista Española de Cardiología (English Edition)|2017|112
Effectiveness of Sacubitril–Valsartan in Cancer Patients with Heart Failure
|ESC Heart Failure|2020|82